Poland's recently-elected government has been tested by the sudden resignation of the Deputy Health Minister after allegations emerged that he might be involved in corrupt payments from drug firms. The Polish Prime Minister, Donald Tusk (Civic Platform), who only took office on November 11 following parliamentary elections in October, accepted the resignation of Boleslaw Piecha (Law and Justice, PiS). The issue is complicated by the fact that the two are members of different coalition parties in the center and center-right government.
Mr Piecha was the subject of local media allegations that he had held private meetings with representatives from pharmaceutical companies to discuss the adoption of new products on the list of state-reimbursed drugs, the UPI news agency reports.
The Polish Dziennik daily newspaper in particular alleged that the disgraced deputy minister had added "an expensive medicine" to the formulary on the same day that he had met with the drug's manufacturer.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze